1. Adler, B. A., Wink, L. K., Early, M., Shaffer, R., Minshawi, N., McDougle, C. J., & Erickson, C. A. (2014). Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: A chart review study. Autism: The International Journal of Research and Practice,. doi: 10.1177/1362361314524641 .
2. Allen, M. H., Debanné, M., Lazignac, C., Adam, E., Dickinson, L. M., & Damsa, C. (2011). Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: A double-blind, randomized, placebo-controlled study. The American Journal of Psychiatry, 168(4), 395–399. doi: 10.1176/appi.ajp.2010.10040569 .
3. Arnold, L. E., Aman, M. G., Hollway, J., Hurt, E., Bates, B., Li, X., et al. (2012). Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 22(3), 198–205. doi: 10.1089/cap.2011.0056 .
4. Arnold, L. E., Anand, R., & Aman, M. (2013). Varencline in autistic disorder: Hypothesis and case report of single-patient crossover. Journal of Child and Adolescent Psychopharmacology,. doi: 10.1089/cap.2012.0025 .
5. Berntson, G. G., Beattie, M. S., & Walker, J. M. (1976). Effects of nicotinic and muscarinic compounds on biting attack in the cat. Pharmacology, Biochemistry and Behavior, 5(3), 235–239.